HomeApplicationsProtein BiologyProtein Labeling & Modification

Protein Labeling & Modification

Fluorescent protein labeling and modification

Proteins are composed of polypeptide chains and their biological functions are determined in part by the correct folding, size, and the number of reactive functional groups present throughout the polypeptide chain. The ability to provide site-specific protein modifications provides researchers with the ability to investigate a wide range of properties and their overall biological function. Protein labeling and modifications technologies include adding fluorophores, biotin, and other small molecules to examine protein-protein interactions, protein folding, to investigate the overall protein structure, and their biological function.

Fluorescent Protein Labeling

The discovery and wide-spread incorporation of green fluorescent protein (GFP) is a powerful example of this technology. GFP and its counterpart molecules have had an enormous impact on numerous fields of study and our understanding of biological processes. For example, the incorporation of fluorescent tags onto antibodies allows for the detection and quantification of highly specific protein complexes in tissues or the directional immobilization of antibody-protein complexes for ELISA and western blot applications. However, a significant disadvantage of using GFP is that the protein function may be disrupted by the incorporation of additional protein tags of this size. To circumvent this challenge, researchers may use smaller fluorescent tags compared to a GFP, biotin, or incorporate non-natural amino acids that contain biorthogonal functionality.

Enzyme-Protein Conjugation

The incorporation of unique enzymes or probes is another method used by researchers to label proteins. Commonly used enzyme-protein conjugations include alkaline phosphatase (AP), and horseradish peroxidase (HRP). There are numerous advantages for using enzyme-protein labeling technologies as they allow for signal amplification, diverse signal outputs, and there are numerous substrates available for each enzyme. Common signal outputs include fluorescent, chemiluminescent, or colorimetric detection. The variety of these signal outputs make them suitable for immunohistochemistry (IHC) or immunofluorescent (IF)-based detection applications in cells and tissues.

Emerging Protein Labeling Technologies

In the field of disease research and drug discovery, targeted protein degradation technology is being intensely studied by researchers to identify novel drug targets and potential therapeutics. Proteolysis-targeting chimeras technology utilizes bifunctional molecules that are designed on one end to bind to a target disease protein, while the other end binds to an E3 ligase to eliminate the protein from the cell. The combined specificity of these molecules to a wide range of disease targets and their ability to target them for protein degradation using internal cellular protein degradation systems make them a powerful protein labeling technology for disease research.


Related Technical Articles

  • Learn more about Mass Spectrometry or MS including what it is, what it is used for and how it works.
  • The extracellular (ECM) microenvironment, defined by biochemical cues and physical cues, is a deciding factor in a wide range of cellular processes including cell adhesion, proliferation, differentiation, and expression of phenotype-specific functions. For this reason, engineering the ECM microenvironment provides clear benefits in studies of cell and tissue engineering and related applications. Currently existing technology offers simple and merely adequate environments that facilitate simple cell processes such as cellular adhesion.1,2 The simple presentation of cell adhesion motifs is not optimal for controlling more integrated processes.
  • β(1→4) Galactosyltransferase from bovine milk (GalT, EC 2.4.1.22) is one of the most extensively studied mammalian glycosyltransferases with regard to synthesis and substrate specificity.
  • Labeling peptides with fluorescent dyes or other labels provides powerful tools for the investigation of biological relevant interactions like receptor-ligand-binding, protein structures, and enzyme activity.
  • COMU is a non-explosive coupling agent suitable for solution phase & solid phase peptide synthesis. Its activity meets or exceeds that of HATU and its water-soluble by-product are easily removed.
  • See All

Related Protocols



Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.